EUVIMEDEUVIMED entdecken
Crossref

Clinical Case: Successful Boost Infusion for Graft Hypofunction After Haploidentical Hematopoietic Stem Cell Transplantation in the Blast Phase of Primary Myelofibrosis

Aisha Adusheva Albertovna, Vadim Kemaykin, Aizat Suleymenova, Saida Yeskendirova, Saltanat Dossayeva, Alexandr Kolesnev, Ruzal Vildanova, Gulzhanat Zhunis, Dina Bashayeva, Tansyk Sergazina

Oncology, Nuclear Medicine and Transplantology · 26.07.2026 · 2 (3) · onmt024

DOI: 10.63946/onmt/19020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology, Nuclear Medicine and Transplantology, erschienen am 26.07.2026. Verfasst von Aisha Adusheva Albertovna und 9 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary myelofibrosis is a myeloproliferative neoplasm characterized by progressive bone marrow fibrosis, splenomegaly, and cytopenic syndrome, leading to a decreased quality of life.

Allogeneic hematopoietic stem cell transplantation (HSCT) remains the only potentially curative method; however, it is associated with the risk of transplant-related complications, including graft hypofunction. This report presents a rare clinical case of graft hypofunction in a patient with primary myelofibrosis after haploidentical HSCT from a related donor (son).

Graft hypofunction is associated with high transplant-related mortality due to infectious complications and hemorrhagic syndrome.

Zitieren

APA

Albertovna, A. A., Kemaykin, V., Suleymenova, A., Yeskendirova, S., Dossayeva, S., Kolesnev, A., Vildanova, R., Zhunis, G., Bashayeva, D., & Sergazina, T. (2026). Clinical Case: Successful Boost Infusion for Graft Hypofunction After Haploidentical Hematopoietic Stem Cell Transplantation in the Blast Phase of Primary Myelofibrosis. Oncology, Nuclear Medicine and Transplantology, 2(3), onmt024. https://doi.org/10.63946/onmt/19020

Vancouver

Albertovna AA, Kemaykin V, Suleymenova A, Yeskendirova S, Dossayeva S, Kolesnev A, et al. Clinical Case: Successful Boost Infusion for Graft Hypofunction After Haploidentical Hematopoietic Stem Cell Transplantation in the Blast Phase of Primary Myelofibrosis. Oncology, Nuclear Medicine and Transplantology. 2026;2(3):onmt024. doi:10.63946/onmt/19020

BibTeX
@article{Albertovna2026,
  author = {Albertovna, Aisha Adusheva and Kemaykin, Vadim and Suleymenova, Aizat and Yeskendirova, Saida and Dossayeva, Saltanat and Kolesnev, Alexandr and Vildanova, Ruzal and Zhunis, Gulzhanat and Bashayeva, Dina and Sergazina, Tansyk},
  title = {Clinical Case: Successful Boost Infusion for Graft Hypofunction After Haploidentical Hematopoietic Stem Cell Transplantation in the Blast Phase of Primary Myelofibrosis},
  journal = {Oncology, Nuclear Medicine and Transplantology},
  year = {2026},
  volume = {2},
  number = {3},
  pages = {onmt024},
  doi = {10.63946/onmt/19020}
}
Kostenlos starten →